FIELD: medicine.
SUBSTANCE: present invention refers to medicine and describes prolonged release therapeutic tablets for oral administration containing a first layer including a first active substance with the first layer arranged between the two adjoining controlled release layers with at least one of said adjoining layers containing at least one second active substance containing acetaminophen with the two adjoining layers enclosed in substantially integrally whole first layer around an external border wherein said tablet provides the applied serum concentration of acetaminophen Tmax from approximately 2 hours to approximately 8 hours after administered in a subject. What is also described is the therapeutic tablet wherein the first layer is provided between the two adjoining controlled release layers combined in one continuous layer. There are described methods for controlling drug release.
EFFECT: invention provides preparing the prolonged release composition of simple formulation and structure which can effectively integrate a number of active substances in a stable state and which can provide effective combination drug-induced treatment over a long periods of time.
44 cl, 10 dwg, 9 tbl, 7 ex
Title | Year | Author | Number |
---|---|---|---|
PER ORALLY DECOMPOSING TABLET COMPOSITIONS, CONTAINING COMBINATIONS OF NON-OPIATE ANALGESICS | 2010 |
|
RU2567032C2 |
COMBINATIONS OF AGONIST/ANTAGONIST FOR OPIOID | 1998 |
|
RU2241458C2 |
FORMULATIONS OF NON-OPIOID AND LIMITED OPIOID ANALGESICS | 2007 |
|
RU2477995C2 |
COMPOSITIONS OF ORALLY DISPERSIBLE TABLETS CONTAINING COMBINATIONS OF HIGH- AND LOW-DOSE THERAPEUTIC AGENTS | 2010 |
|
RU2554740C2 |
ABUSE-RESISTANT PHARMACEUTICAL COMPOSITIONS | 2015 |
|
RU2764569C2 |
SYNERGETIC ANALGETIC COMBINATION OF OPIOID ANALGETIC AGENT AND CYCLOOXYGENASE-2 INHIBITOR | 1998 |
|
RU2232600C2 |
MEDICAL FORM AND METHOD FOR DELIVERY OF HABIT-FORMING MEDICAL SUBSTANCES | 2007 |
|
RU2433817C2 |
PHARMACEUTICAL DOSAGE FORMS AND COMPOSITIONS OF COLON ABSORBED PHENYLEPHRINE | 2007 |
|
RU2454225C2 |
PHENYLEPHRINE RESINATE PARTICLES | 2014 |
|
RU2675788C2 |
COATED PHENYLEPHRINE PARTICLES AND USE THEREOF IN PHARMACEUTICAL FORMULATIONS | 2014 |
|
RU2681312C2 |
Authors
Dates
2012-10-10—Published
2007-07-19—Filed